Search Results 1101-1110 of 16332 for Chronic Lymphocytic Leukemia
Phase 4 trials look at long-term safety and ... leukemia that has come back after treatment ... Patients must have had histologic verification of AML at original ...
This study is being done to learn more about diseases with chronic and harmful inflammation. This study will look at what causes these diseases; whether ...
Prior treatment for lymphoid malignancy (applies to Part 1 and Part 2): ... leukemia):. Confirmed diagnosis of previously ... chronic obstructive pulmonary disease, ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...
Learn about kidney failure symptoms, tests, diagnosis and treatment options, including medication, dialysis and kidney transplant.
The primary purpose for this study is to assess if any relationship exists between participation in the Fibromyalgia and Chronic Fatigue Clinic (FCFC) class ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
Large B-cell lymphoma with IRF4 rearrangement. Primary cutaneous DLBCL, leg type. EBV positive DLBCL, NOS. DLBCL associated with chronic inflammation.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact 2X.